Target intelligence / Profile preview

LOXL2 antisense RNA 1 (LOXL2-AS1)

Target
LOXL2-AS1
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

LOXL2 antisense RNA 1 (LOXL2-AS1) is a long non-coding RNA gene transcribed from the LOXL2 gene locus but on the antisense strand. Unlike LOXL2, which is a lysyl oxidase-like enzyme involved in extracellular matrix remodeling, LOXL2-AS1 does not code for a protein and does not function as a classical drug target (such as a receptor or enzyme). Instead, LOXL2-AS1 may play a regulatory role in gene expression at the RNA level—potentially impacting the expression or function of the neighboring LOXL2 gene through antisense RNA-mediated mechanisms. There is currently no evidence that LOXL2-AS1 is itself a direct disease driver or a therapeutic target, nor is it associated with any approved or experimental drugs, mechanisms of pharmacological action, or routine use as a biomarker for patient selection or efficacy monitoring. Its biological and disease associations, if any, remain poorly characterized and are largely inferential from antisense RNA biology and genomic context[3].

Other names
LOXL2-AS1AC090197.1
02

Biological functions

Regulation of gene expressionModulation of LOXL2 gene expressionPotential regulation of mRNA stability and localization
03

Disease associations

Possibly involved in cancer (indirectly, through regulation of LOXL2)Other (no direct disease-modifying role established)

Beyond the preview

Go deeper on LOXL2 antisense RNA 1 (LOXL2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LOXL2 antisense RNA 1 (LOXL2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call